PCAIs stimulate MAPK, PI3K/AKT pathways and ROS-Mediated apoptosis in aromatase inhibitor-resistant breast cancer cells while disrupting actin filaments and focal adhesion

Jassy Mary S. Lazarte(Florida Agricultural and Mechanical University), Nazarius S. Lamango(Florida Agricultural and Mechanical University)

Oncotarget

July 29, 2025

10.18632/oncotarget.28759

Cited by 2

Related Papers

Polyisoprenylated cysteinyl amide inhibitors disrupt actin cytoskeleton organization, induce cell rounding and block migration of non-small cell lung cancer

|Oncotarget|2017|21

Activation of MAP Kinase Pathway by Polyisoprenylated Cysteinyl Amide Inhibitors Causes Apoptosis and Disrupts Breast Cancer Cell Invasion

|Biomedicines|2024|5

Treatment of a mutant KRAS lung cancer cell line with polyisoprenylated cysteinyl amide inhibitors activates the MAPK pathway, inhibits cell migration and induces apoptosis

|PLoS ONE|2024|5

Engineered Nanobody-Bearing Extracellular Vesicles Enable Precision Trop2 Knockdown in Resistant Breast Cancer

|Pharmaceutics|2025|3